Table 2.
Synthesis table.
| Study (number of participants) |
|||||||||
| Predictors |
Hsu et al. (2021) (n = 110,044) |
Lewis et al. (2019) (n = 2,814,041) |
Meisel et al. (2010) (n = 683) |
Rothrock et al. (2001) (n = 2858) |
Dawson et al. (2023) (n = 256,901) |
Muhrbeck et al. (2020) (n = 539) |
Melberg et al. (2013) (n = 244) |
Banks & Dracup (2007) (n = 61) |
O’Donnell et al. (2006) (n = 890) |
| Patient sex | |||||||||
| Male | 70,495 | 1,153,769 | 342 | 1350 | 127,805 | 385 | 179 | 32 | 613 |
| Female | 39,549 | 1,223,754 | 341 | 1508 | 129,096 | 154 | 65 | 29 | 277 |
| Ambulance response times for women (compared to men) | OR: 0.99 95% CI: 0.98–1.01 |
14 minutes compared to 13 minutes p-value = 0.084 |
57 minutes compared to 35 minutes p-value = 0.006 |
||||||
| Symptom to ED time for women taken via ambulance (compared to men) | 3.1 hours compared to 0.58 hours p-value = 0.04 |
14 hours compared to 2.8 hours p-value = < 0.0001 |
|||||||
| Ambulance arrival to ECG in 10 minutes for women (compared to men) | 99 minutes compared to 19 minutes p-value = 0.001 |
||||||||
| Women receiving ECG assessment (compared to men) | OR: 0.88 CI: 0.83–0.92 12% less likely than men |
48.8% compared to 50.5% Difference: -2.7% 95% CI: -5.7, 2.2 |
OR: 0.80 79% compared to 82% p-value = 0.21 |
OR: 0.50 39.3% compared 46.8% p-value = < 0.001 |
OR: 0.82 95% CI: 0.81–0.83 |
||||
| Women receiving aspirin (compared to men) | OR: 0.79 CI: 0.76–0.81 21% less likely than men |
42.5% compared to 45.3% Difference: -2.8% 95% CI: -4.8, -0.8 |
OR: 0.60 24% compared to 32% p-value = 0.03 |
OR: 0.71 35.4% compared to 42.3% p-value = < 0.001 |
OR: 0.86 95% CI: 0.84–0.87 |
||||
| Women receiving GTN (compared to men) | OR: 0.84 CI: 0.81–0.86 16% less likely than men |
41% compared to 43.7% Difference: -2.7% 95% CI: -4.8, -0.6 |
OR: 0.60 26% compared to 33% p-value = 0.02 |
OR: 1.0 32.9% compared to 33.1% p-value = 0.569 |
|||||
| Women receiving analgesic administration for pain (compared to men) | OR: 0.85 95% CI: 0.83–0.88 |
||||||||